Matthew Wein, Officer of Metagenomi Therapeutics MGX, has filed 0 purchases and 6 sales on the open market. Over the past 12 months that comes to a net sale of $1,849. The latest trade was on 06/05.

MW

MW

Matthew Wein

SEE REMARKS

Company

Metagenomi Therapeutics MGX

First filing

24/04/03

Trades

15 trades

Buys / sales

0 / 6

12-month net buying

−$1,849

Last trade

06/05

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Metagenomi TherapeuticsMGX	Open-market sale	06/05	06/10	558 sh	$1.30	$725.4	−0.4%
Metagenomi TherapeuticsMGX	Open-market sale	03/05	03/09	482 sh	$1.60	$771.2	−0.4%
Metagenomi TherapeuticsMGX	Open-market sale	25/12/05	25/12/08	199 sh	$1.77	$352.23	−0.2%
Metagenomi TherapeuticsMGX	Open-market sale	25/09/05	25/12/01	199 sh	$1.81	$360.19	−1.0%
Metagenomi TherapeuticsMGX	Open-market sale	25/06/06	25/06/09	199 sh	$1.75	$348.25	−1.2%
Metagenomi TherapeuticsMGX	Open-market sale	25/03/05	25/03/07	930 sh	$1.87	$1,739.1	−8.9%